| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Granulosa Cells | 13 | 2020 | 21 | 3.650 |
Why?
|
| Ovary | 11 | 2017 | 99 | 2.680 |
Why?
|
| Oocytes | 5 | 2020 | 57 | 1.880 |
Why?
|
| GATA4 Transcription Factor | 8 | 2014 | 33 | 1.500 |
Why?
|
| Phosphoproteins | 7 | 2012 | 202 | 1.500 |
Why?
|
| Progesterone Reductase | 3 | 2019 | 3 | 1.420 |
Why?
|
| GATA6 Transcription Factor | 6 | 2014 | 27 | 1.150 |
Why?
|
| Ovarian Follicle | 7 | 2020 | 21 | 1.110 |
Why?
|
| Follicle Stimulating Hormone | 4 | 2020 | 29 | 1.100 |
Why?
|
| Steroid Isomerases | 2 | 2019 | 2 | 1.090 |
Why?
|
| Multienzyme Complexes | 2 | 2019 | 50 | 1.070 |
Why?
|
| Progesterone | 3 | 2020 | 115 | 1.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 2022 | 85 | 0.970 |
Why?
|
| Swine | 7 | 2017 | 672 | 0.940 |
Why?
|
| Receptors, LH | 3 | 2019 | 4 | 0.890 |
Why?
|
| Fertilization in Vitro | 2 | 2020 | 47 | 0.850 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 562 | 0.840 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 3 | 2012 | 4 | 0.810 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 1293 | 0.790 |
Why?
|
| Transcription Factors | 5 | 2005 | 753 | 0.730 |
Why?
|
| Testis | 3 | 2012 | 37 | 0.700 |
Why?
|
| Ventricular Remodeling | 1 | 2022 | 318 | 0.690 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2019 | 3 | 0.680 |
Why?
|
| Amphiregulin | 1 | 2019 | 19 | 0.680 |
Why?
|
| RNA, Messenger, Stored | 1 | 2018 | 2 | 0.660 |
Why?
|
| Matrix Metalloproteinase 15 | 1 | 2018 | 5 | 0.660 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2018 | 24 | 0.650 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2018 | 22 | 0.640 |
Why?
|
| RNA, Messenger | 9 | 2019 | 1664 | 0.630 |
Why?
|
| DNA-Binding Proteins | 5 | 2010 | 700 | 0.630 |
Why?
|
| Heart | 1 | 2022 | 850 | 0.600 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 144 | 0.600 |
Why?
|
| Pregnancy | 10 | 2022 | 2334 | 0.570 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 167 | 0.570 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 110 | 0.570 |
Why?
|
| Animals | 25 | 2022 | 20881 | 0.560 |
Why?
|
| Mitochondria | 1 | 2020 | 643 | 0.520 |
Why?
|
| Cyclic AMP | 3 | 2014 | 223 | 0.500 |
Why?
|
| Female | 27 | 2022 | 38074 | 0.490 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2005 | 3 | 0.490 |
Why?
|
| Histones | 2 | 2005 | 111 | 0.480 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1034 | 0.470 |
Why?
|
| Heart Ventricles | 1 | 2018 | 738 | 0.470 |
Why?
|
| Luteinization | 2 | 2010 | 3 | 0.450 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 81 | 0.450 |
Why?
|
| Stilbenes | 5 | 2014 | 57 | 0.420 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2019 | 328 | 0.410 |
Why?
|
| Gene Expression | 3 | 2011 | 770 | 0.410 |
Why?
|
| Osteopontin | 1 | 2011 | 28 | 0.380 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2011 | 17 | 0.380 |
Why?
|
| Biomarkers | 1 | 2016 | 1593 | 0.380 |
Why?
|
| Thyroid Hormones | 1 | 2011 | 31 | 0.380 |
Why?
|
| Sus scrofa | 3 | 2010 | 74 | 0.360 |
Why?
|
| Maternal Exposure | 1 | 2011 | 75 | 0.360 |
Why?
|
| Embryonic Development | 3 | 2020 | 100 | 0.360 |
Why?
|
| Corpus Luteum | 5 | 2014 | 8 | 0.350 |
Why?
|
| Immunohistochemistry | 6 | 2014 | 1174 | 0.330 |
Why?
|
| Cumulus Cells | 2 | 2019 | 2 | 0.310 |
Why?
|
| Embryo Transfer | 2 | 2019 | 18 | 0.310 |
Why?
|
| Reproduction | 2 | 2007 | 48 | 0.300 |
Why?
|
| Pregnancy in Diabetics | 3 | 2013 | 70 | 0.290 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 434 | 0.280 |
Why?
|
| Cells, Cultured | 7 | 2011 | 2673 | 0.270 |
Why?
|
| Estrous Cycle | 2 | 2017 | 23 | 0.260 |
Why?
|
| Molecular Sequence Data | 5 | 2009 | 1447 | 0.260 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 6 | 0.250 |
Why?
|
| Protein Isoforms | 2 | 2005 | 246 | 0.250 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 357 | 0.250 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 95 | 0.240 |
Why?
|
| Epigenesis, Genetic | 1 | 2005 | 163 | 0.230 |
Why?
|
| Postpartum Period | 2 | 2022 | 67 | 0.230 |
Why?
|
| Transcription Factor AP-1 | 1 | 2003 | 61 | 0.220 |
Why?
|
| Base Sequence | 3 | 2011 | 1015 | 0.210 |
Why?
|
| Receptors, Estrogen | 1 | 2002 | 142 | 0.190 |
Why?
|
| RNA Interference | 2 | 2014 | 266 | 0.190 |
Why?
|
| Blastocyst | 1 | 2020 | 17 | 0.180 |
Why?
|
| Follicular Fluid | 1 | 2020 | 18 | 0.180 |
Why?
|
| Mice | 3 | 2022 | 8474 | 0.180 |
Why?
|
| Stroke Volume | 1 | 2022 | 586 | 0.180 |
Why?
|
| In Vitro Oocyte Maturation Techniques | 1 | 2019 | 1 | 0.170 |
Why?
|
| Oocyte Retrieval | 1 | 2019 | 4 | 0.170 |
Why?
|
| Oogenesis | 1 | 2019 | 10 | 0.170 |
Why?
|
| Ploidies | 1 | 2019 | 6 | 0.170 |
Why?
|
| COS Cells | 2 | 2014 | 155 | 0.160 |
Why?
|
| Collagen Type III | 1 | 2018 | 21 | 0.160 |
Why?
|
| Mice, Knockout | 1 | 2022 | 1692 | 0.160 |
Why?
|
| Proteoglycans | 1 | 2018 | 103 | 0.160 |
Why?
|
| Collagen Type I | 1 | 2018 | 175 | 0.150 |
Why?
|
| Gene Silencing | 2 | 2010 | 137 | 0.150 |
Why?
|
| Steroids | 2 | 2012 | 84 | 0.150 |
Why?
|
| Cell Nucleus | 3 | 2003 | 305 | 0.140 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2017 | 26 | 0.140 |
Why?
|
| Transfection | 3 | 2004 | 782 | 0.140 |
Why?
|
| Ovulation Induction | 1 | 2016 | 9 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2020 | 867 | 0.140 |
Why?
|
| Transcriptional Activation | 2 | 2012 | 226 | 0.140 |
Why?
|
| Rats | 6 | 2012 | 5300 | 0.140 |
Why?
|
| Adult | 3 | 2020 | 21403 | 0.140 |
Why?
|
| Cachexia | 1 | 2017 | 54 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 176 | 0.130 |
Why?
|
| Humans | 10 | 2020 | 68618 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 2550 | 0.130 |
Why?
|
| Echocardiography | 1 | 2018 | 515 | 0.130 |
Why?
|
| Acetylation | 2 | 2005 | 94 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 2791 | 0.120 |
Why?
|
| Transcriptome | 1 | 2016 | 164 | 0.120 |
Why?
|
| Theca Cells | 2 | 2005 | 3 | 0.120 |
Why?
|
| Histone Deacetylases | 2 | 2005 | 99 | 0.120 |
Why?
|
| Fetal Diseases | 2 | 2012 | 64 | 0.120 |
Why?
|
| Transglutaminases | 1 | 2014 | 67 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 396 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 196 | 0.110 |
Why?
|
| Tissue Distribution | 2 | 2003 | 282 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2014 | 525 | 0.100 |
Why?
|
| Neural Tube Defects | 1 | 2012 | 27 | 0.100 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2012 | 48 | 0.100 |
Why?
|
| Luteal Cells | 1 | 2012 | 1 | 0.100 |
Why?
|
| Leydig Cells | 1 | 2012 | 5 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2005 | 1200 | 0.100 |
Why?
|
| Diabetes Complications | 1 | 2013 | 249 | 0.100 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2011 | 27 | 0.100 |
Why?
|
| Radioimmunoassay | 1 | 2011 | 164 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 240 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 250 | 0.090 |
Why?
|
| 5' Flanking Region | 1 | 2010 | 8 | 0.090 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
| DNA Primers | 1 | 2011 | 302 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 60 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 332 | 0.090 |
Why?
|
| Cerebellum | 1 | 2011 | 103 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1083 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 1745 | 0.090 |
Why?
|
| DNA | 2 | 2003 | 597 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 362 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2011 | 110 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 492 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 756 | 0.090 |
Why?
|
| Isoenzymes | 1 | 2010 | 308 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2011 | 718 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 320 | 0.080 |
Why?
|
| Lipids | 1 | 2011 | 298 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2009 | 167 | 0.080 |
Why?
|
| Ovulation | 1 | 2008 | 10 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 498 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2011 | 631 | 0.070 |
Why?
|
| Male | 5 | 2012 | 37321 | 0.070 |
Why?
|
| Apoptosis | 2 | 2011 | 1641 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 447 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 114 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2012 | 659 | 0.070 |
Why?
|
| Inhibins | 1 | 2005 | 6 | 0.070 |
Why?
|
| Methylation | 1 | 2005 | 56 | 0.070 |
Why?
|
| Chromatin | 1 | 2005 | 76 | 0.060 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2005 | 6 | 0.060 |
Why?
|
| Zinc Fingers | 1 | 2004 | 17 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2005 | 57 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 64 | 0.060 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2004 | 32 | 0.060 |
Why?
|
| Ethanol | 1 | 2011 | 893 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2016 | 7029 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2005 | 93 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2004 | 289 | 0.060 |
Why?
|
| Sex Differentiation | 1 | 2003 | 6 | 0.060 |
Why?
|
| Sex Determination Processes | 1 | 2003 | 6 | 0.060 |
Why?
|
| Histology | 1 | 2003 | 7 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 204 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2004 | 116 | 0.060 |
Why?
|
| Microscopy | 1 | 2003 | 64 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2003 | 150 | 0.060 |
Why?
|
| Computer-Assisted Instruction | 1 | 2003 | 74 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2003 | 20 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2003 | 34 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 71 | 0.050 |
Why?
|
| Placenta | 1 | 2003 | 101 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 370 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 331 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 114 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2003 | 155 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 411 | 0.050 |
Why?
|
| Chorionic Gonadotropin | 1 | 2002 | 7 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2003 | 230 | 0.050 |
Why?
|
| Luteal Phase | 1 | 2002 | 25 | 0.050 |
Why?
|
| Estrogen Receptor beta | 1 | 2002 | 19 | 0.050 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2003 | 148 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 615 | 0.050 |
Why?
|
| Exons | 1 | 2002 | 122 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2002 | 93 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 282 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2002 | 254 | 0.050 |
Why?
|
| Internet | 1 | 2003 | 390 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 710 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1033 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2014 | 97 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 1038 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 280 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2014 | 231 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2014 | 362 | 0.030 |
Why?
|
| Cell Movement | 1 | 2014 | 630 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 160 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 94 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2011 | 203 | 0.020 |
Why?
|
| Caspases | 1 | 2011 | 194 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 791 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 343 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 499 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 529 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Pregnancy, Animal | 1 | 2007 | 27 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 2083 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2003 | 219 | 0.010 |
Why?
|
| Schools, Medical | 1 | 2003 | 157 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 4655 | 0.010 |
Why?
|
| South Carolina | 1 | 2003 | 2752 | 0.010 |
Why?
|